 |
Antisense oligonucleotide complementary to the exonic splicer enhancer sequence at intron 26 of the centrosomal protein 290 pre-mRNA |
|---|---|
| Trade Name | |
| Orphan Indication | Leber congenital amaurosis |
| EU Market Approval | EU |
| EU Designation Date | 2016-04-28 00:00:00 |
| Sponsor | ProQR Therapeutics IV BV |
